Machine Learning Applied to Clinical Laboratory Data Predicts Patient-Specific, Near-Term Relapse in Patients in Medication for Opioid Use Disorder Treatment
Pyzowski, P.; Herbert, B.; Malik, W. Q.
Show abstract
We have developed a data-driven, algorithmic method for identifying patients in an out-patient buprenorphine program at high risk for relapse in the following seven days. This method uses data already available in clinical laboratory data, can be made available in a timely matter, and is easily understandable and actionable by clinicians. Use of this method could significantly reduce the rate of relapse in addiction treatment programs by targeting interventions at those patients most at risk for near term relapse.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Optimising supervised machine learning algorithms predicting cigarette cravings and lapses for a smoking cessation just-in-time adaptive intervention (JITAI) 92%
- A study of psychological pain in substance use disorder and its relationship to treatment outcome 92%
- Estimating The Uncertain Effect of the COVID Pandemic on Drug Overdoses 91%
Similar papers in this journal
- Medication Improves Age Disparities in Six-Month Treatment Retention for Opioid Use Disorder 91%
- Changes in injecting versus smoking heroin, fentanyl, and methamphetamine among people who inject drugs in San Diego, California, 2020 to 2023 91%
- Steep increases in fentanyl-related mortality west of the Mississippi River: synthesizing recent evidence from county and state surveillance 91%
Similar papers in this journal
- Toward Evaluation of Disseminated Effects of Medications for Opioid Use Disorder within Provider-Based Clusters Using Routinely-Collected Health Data 93%
- Sensitivity to missing not at random dropout in clinical trials: use and interpretation of the Trimmed Means Estimator 89%
- A Markov Chain approach for ranking treatments in network meta-analysis 88%
Similar papers in this journal
- WITHDRAWN: Comparative effectiveness of extended release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients 92%
- Cognitive training and remediation interventions for substance use disorders: A Delphi consensus study 91%
- Efficacy of a personalised alcohol approach bias modification smartphone app in people accessing outpatient alcohol use disorder treatment: A randomised controlled trial 90%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.